Up to 80 percent of oncology trials miss accrual timelines due to eligibility compression and weak prescreen design. This session outlines how Gabrail Cancer Center converts clinical access and workflow discipline into predictable enrollment velocity.
Who Should Attend
• Biotech Clinical Operations Leaders
• CRO Site Selection Teams
• VP Clinical Development
• Oncology Program Directors
• Study Start-Up Executives
Agenda
Structural Causes of Oncology Accrual Failure: Enrollment breakdowns typically stem from design and workflow failures, not a lack of patients.
Community Oncology Advantage: Community access reduces academic bottlenecks and increases screening throughput.
Prescreen Infrastructure as a Leading KPI: Real-time identification predicts accrual durability before timelines slip.
Activation Velocity and Time-to-First-Screen: Early screening speed is a predictive signal of enrollment stability.
Sponsor Metrics That Predict Enrollment Stability: Screen-to-enroll ratios and cohort momentum reveal trial viability early.
Q & A – Polls – Handouts We will collect your input through live polls, answer executive questions, and provide a downloadable Accrual Readiness resource.
Duration
1 hour
Price
Free
Language
English
OPEN TO
Everyone
Dial-in Number
Please register for this Webinar to view the dial-in info.
Dr. Gabrail is a graduate of Mosul Medical School in Iraq. He completed his graduate Internal Medicine education at The University of Edinburgh, Scotland and Hematology/Oncology in Glasgow, Scotland.
Carrie Smith, R.N. began her oncology career in 1998 as an oncology nurse at Gabrail Cancer Center. The following year she realized that access to clinical trials should be the preferred standard of care for all cancer patients. Carrie was...
Gabrail Cancer & Research Center: Founded by Dr. Nashat Gabrail in 1990, the Gabrail Cancer Center was opened in Stark County in Ohio. Due to the increasing amount of patients traveling long distances for treatment, a satellite office was opened...
About BioAlliance Strategies
Founded in 2011, BioAlliance Strategies solves a persistent problem in life sciences growth. There was a definite need to build a revenue infrastructure system for smaller companies where high-dollar sales teams...